Leptin in type 2 diabetic or myotonic dystrophic women

被引:6
作者
Gómez, JM [1 ]
Molina, A [1 ]
Fernández-Castañer, M [1 ]
Soler, J [1 ]
机构
[1] Ciudad Sanitaria & Univ Bellvitge, Hosp Llobregat, Serv Endocrinol, Barcelona, Spain
关键词
body composition; body fat; fat mass; insulin; insulin resistance; leptin; myotonic dystrophy; type; 2; diabetes;
D O I
10.1055/s-2001-14944
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Insulin resistance is an important determinant of circulating leptin concentrations in humans, but its independent contribution on plasma leptin levels are controversial. In the present study, we characterized plasma leptin levels and their regulation in women with 2 different insulin resistance states: type 2 diabetes and myotonic dystrophy disease, and in controls. Material and Methods: We studied 3 groups of women: 21 type 2 diabetic patients, 20 myotonic dystrophic patients and a control group of 20 normoglycemic subjects, matched in age and body mass index. Body composition, fasting glucose and insulin, IGF-I, ICF-binding protein-3 and leptin were studied. Body composition was measured using a bioelectrical impedance analyser. Insulin sensitivity tin percentage) was modeled according to a computer-based homeostasis model assessment model. Data are expressed in mean +/- SEM. Results: In both groups of patients, glucose concentrations were higher in type 2 diabetic patients than in myotonic dystrophic patients, and insulin concentrations and insulin sensitivity were similar in the 2 groups of patients (82.4 +/- 18.6% in type 2 diabetic patients vs. 69.7 +/- 9.7% in myotonic dystrophic patients, p = 0.2) and lower than in controls. Serum leptin and leptin/fat mass ratio were higher in myotonic dystrophic patients than in type 2 diabetic patients (30 +/- 4.9 ng/ml vs. 17.7 +/- 2.6 ng/ml, p = 0.03 and 2.32 +/- 0.69 ng/ml/kg vs. 1.07 +/- 0.2 ng/ml/kg, p = 0.02, respectively) or those found in controls. In type 2 diabetic patients, leptin concentrations were correlated with body mass index and body fat, and in myotonic dystrophic patients leptin concentrations were correlated with age, body mass index, fasting insulin and lower insulin sensitivity, whereas leptin concentrations were not correlated with body fat. Conclusions: These findings suggest that leptin concentrations and regulation in myotonic dystrophic patients are different from type 2 diabetes.
引用
收藏
页码:246 / 249
页数:4
相关论文
共 22 条
  • [1] Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
    Bonora, E
    Saggiani, F
    Targher, G
    Zenere, MB
    Alberiche, M
    Monauni, T
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES CARE, 2000, 23 (01) : 57 - 63
  • [2] Modulation of insulin activities by leptin
    Cohen, B
    Novick, D
    Rubinstein, M
    [J]. SCIENCE, 1996, 274 (5290) : 1185 - 1188
  • [3] Serum immunoreactive leptin concentrations in normal-weight and obese humans
    Considine, RV
    Sinha, MK
    Heiman, ML
    Kriauciunas, A
    Stephens, TW
    Nyce, MR
    Ohannesian, JP
    Marco, CC
    McKee, LJ
    Bauer, TL
    Caro, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 292 - 295
  • [4] Leptin: A significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women
    Dua, A
    Hennes, MI
    Hoffmann, RG
    Maas, DL
    Krakower, GR
    Sonnenberg, GE
    Kissebah, AH
    [J]. DIABETES, 1996, 45 (11) : 1635 - 1637
  • [5] Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy
    Fernández-Real, JM
    Molina, A
    Broch, M
    Ricart, W
    Gutiérrez, C
    Casamitjana, R
    Vendrell, J
    Soler, J
    Gómez-Sáez, JM
    [J]. DIABETES, 1999, 48 (05) : 1108 - 1112
  • [6] Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance
    Fernández-Real, JM
    Broch, M
    Ricart, W
    Casamitjana, R
    Gutierrez, C
    Vendrell, J
    Richart, C
    [J]. DIABETES, 1998, 47 (11) : 1757 - 1762
  • [7] FernandezCastaner M, 1996, DIABETIC MED, V13, P953, DOI 10.1002/(SICI)1096-9136(199611)13:11<953::AID-DIA257>3.0.CO
  • [8] 2-V
  • [9] Insulin regulation of leptin synthesis and secretion in humans:: the model of myotonic dystrophy
    Gómez, JM
    Molina, A
    Fernández-Castañer, M
    Casamitjana, R
    Martínez-Matos, JA
    Soler, J
    [J]. CLINICAL ENDOCRINOLOGY, 1999, 50 (05) : 569 - 575
  • [10] Leptin concentrations in diabetic and nondiabetic Mexican-Americans
    Haffner, SM
    Stern, MP
    Miettinen, H
    Wei, M
    Gingerich, RL
    [J]. DIABETES, 1996, 45 (06) : 822 - 824